Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

TransMedics (TMDX) Cost of Revenue (2018 - 2026)

TransMedics has reported Cost of Revenue over the past 8 years, most recently at $67.4 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 35.76% year-over-year to $67.4 million; the TTM value through Dec 2025 reached $242.7 million, up 35.23%, while the annual FY2025 figure was $242.7 million, 35.23% up from the prior year.
  • Cost of Revenue for Q4 2025 was $67.4 million at TransMedics, up from $59.2 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $67.4 million in Q4 2025 and troughed at $1.6 million in Q3 2021.
  • A 5-year average of $27.3 million and a median of $20.7 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: decreased 22.21% in 2021 and later skyrocketed 373.89% in 2022.
  • Year by year, Cost of Revenue stood at $2.7 million in 2021, then soared by 297.91% to $10.7 million in 2022, then soared by 211.56% to $33.2 million in 2023, then skyrocketed by 49.21% to $49.6 million in 2024, then surged by 35.76% to $67.4 million in 2025.
  • Business Quant data shows Cost of Revenue for TMDX at $67.4 million in Q4 2025, $59.2 million in Q3 2025, and $60.8 million in Q2 2025.